中国医学创新
中國醫學創新
중국의학창신
MEDICAL INNOVATION OF CHINA
2014年
12期
4-6,7
,共4页
连晓峰%夏永华%许志强%韩鹏%李永锋%李勇%张海瑞%贾民勇
連曉峰%夏永華%許誌彊%韓鵬%李永鋒%李勇%張海瑞%賈民勇
련효봉%하영화%허지강%한붕%리영봉%리용%장해서%가민용
呼吸衰竭%预后%急性生理及慢性健康状况
呼吸衰竭%預後%急性生理及慢性健康狀況
호흡쇠갈%예후%급성생리급만성건강상황
Respiratory failure%Outcome%APACHE
目的:试图比较现行三种预后评分对呼吸衰竭患者预后的判别能力;方法:选取2009年1月-2012年3月入住本院符合呼吸衰竭诊断标准的138例患者,应用三种不同评分(APACHEⅡ,APACHEⅢ和SAPSⅡ)评估其预后情况,根据入院30 d存活情况比较不同评分的预测能力。结果:死亡组患者三种评分分值均明显高于存活组,同时ICU住院天数明显短于存活组,差异均有统计学意义(P<0.001);其中SAPSⅡ敏感度最高,三种评分受试者工作曲线的曲线下面积均在0.8以上。结论:现行三种评分均可较好地预测呼吸衰竭患者的预后,值得临床推广。
目的:試圖比較現行三種預後評分對呼吸衰竭患者預後的判彆能力;方法:選取2009年1月-2012年3月入住本院符閤呼吸衰竭診斷標準的138例患者,應用三種不同評分(APACHEⅡ,APACHEⅢ和SAPSⅡ)評估其預後情況,根據入院30 d存活情況比較不同評分的預測能力。結果:死亡組患者三種評分分值均明顯高于存活組,同時ICU住院天數明顯短于存活組,差異均有統計學意義(P<0.001);其中SAPSⅡ敏感度最高,三種評分受試者工作麯線的麯線下麵積均在0.8以上。結論:現行三種評分均可較好地預測呼吸衰竭患者的預後,值得臨床推廣。
목적:시도비교현행삼충예후평분대호흡쇠갈환자예후적판별능력;방법:선취2009년1월-2012년3월입주본원부합호흡쇠갈진단표준적138례환자,응용삼충불동평분(APACHEⅡ,APACHEⅢ화SAPSⅡ)평고기예후정황,근거입원30 d존활정황비교불동평분적예측능력。결과:사망조환자삼충평분분치균명현고우존활조,동시ICU주원천수명현단우존활조,차이균유통계학의의(P<0.001);기중SAPSⅡ민감도최고,삼충평분수시자공작곡선적곡선하면적균재0.8이상。결론:현행삼충평분균가교호지예측호흡쇠갈환자적예후,치득림상추엄。
Objective:To investigate the capability of three scoring systems in patients with respiratory failure. Method:138 patients diagnosed as respiratory failure admitted to our hospital from January 2009 to March 2012 were selected, and evaluated their prognosis with three scoring systems(APACHE Ⅱ,APACHE Ⅲand SAPSⅡ),and according to the admission of 30 d survival,the predictive ability of these scoring systems were compared.Result:Prognosis scores of three scoring systems in the death group were significantly higher than those of the survival group,at the same time,length of ICU stay was significantly shorter than the survival group,the differences were statistically significant(P<0.001).Among them SAPS Ⅱwas the highest sensitivity,the area under curve of ROC of the three systems were all above 0.8.Conclusion:The existing three scoring can well predict the prognosis of patients with respiratory failure,is worthy of clinical promotion.